Tenax Therapeutics, Inc.TENX
Price (close)
$1.89
Market cap
$60.4M
P/E
—
Revenue (TTM)
$0
Net income
-$64.9M
Dividend yield
—
1-year total return
-72.2%
Net margin
—
Revenue growth
—
Debt / equity
—
What Tenax Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $0 |
| Net income | -$9.9M | -$32.5M | $11.0M | -$7.7M | -$17.6M | -$52.6M |
| Free cash flow | -$9.3M | -$10.9M | -$11.4M | — | — | — |
More on TENX.
- Tenax Therapeutics, Inc. summary
- Tenax Therapeutics, Inc. financial statements
- Tenax Therapeutics, Inc. key metrics
- Tenax Therapeutics, Inc. health scores and style box
- Tenax Therapeutics, Inc. earnings
- Tenax Therapeutics, Inc. dividends
- Tenax Therapeutics, Inc. valuation
- Tenax Therapeutics, Inc. ownership and insiders
- Tenax Therapeutics, Inc. peers
Figures from Tenax Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.